The Latest Breaking News on Pharma

The Irish public has been warned against stockpiling medication as it could 'disrupt existing stock levels and hamper the supply of medicines for others'

Some medicines are not expected to be back in stock for months - with Benylin Dry Coughs Syrup expected to remain off the shelves until April

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level.

Derek Dragsnes manufactured the drug etizolam at an industrial unit in North Lanarkshire.

Despite various macroeconomic headwinds, the healthcare industry is well-positioned to cope well due to the inelastic demand for products and services. Moreover, expanding R&D initiatives and favorable government funding should accelerate the industry's growth. Therefore, fundamentally sound medical stocks Premier Inc. (PINC) could be a wise addition to one's portfolio.…

Regeneron Pharmaceuticals said sales of its linchpin Eylea drug have been negatively impacted by a short-term shift to rival drug Avastin.

AstraZeneca said it has agreed to buy CinCor Pharma, maker of clinical-stage blood pressure drug baxdrostat, in a deal valued at $1.8 billion.

Pharmacists claim that the shortages have been ongoing for several months and include medications used to treat the Strep A infection, which can cause serious illness amongst young children and elderly adults